Streetbeat News

Products Services

GOOGL

Google will start accepting and running ads for affiliates with eligibility permits from the Hellenic Gaming Commission starting September 30, 2024. This update will be reflected on the Gambling & Games Policy page.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 4:07 pm

BGLC

BioNexus Gene Lab Corp. has signed a strategic outsourcing agreement with VITARRAY Global to provide mRNA dynamic gene detection services in Southeast Asia. This collaboration aims to enhance molecular diagnostics and early disease detection in the region.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 4:06 pm

BA

Boeing's CFO highlighted significant supply chain constraints affecting the aerospace industry, particularly impacting widebody aircraft deliveries. This was discussed at Morgan Stanley's 12th Annual Laguna Conference 2024.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 4:01 pm

DIA

IWM

QQQ

SPY

UUP

XLB

Consumer sentiment in the US has reached a four-month high, driven by easing inflation expectations. This has positively impacted stock markets, with major ETFs like SPY, QQQ, IWM, DIA, and XLB showing gains. The US dollar weakened, affecting the UUP ETF.

Portfolio Pulse from Piero Cingari

September 13, 2024 | 4:00 pm

ALGN

Align Tech (NASDAQ:ALGN) has been analyzed by 7 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $325, down 7.07% from the previous $349.71. Analysts have adjusted their ratings and price targets, reflecting evolving market conditions. Align Tech is a leading manufacturer of clear aligners, with strong financial metrics such as a high net margin and ROE, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

September 13, 2024 | 4:00 pm

NBIX

Neurocrine Biosciences' phase two trial of luvadaxistat for schizophrenia failed to meet its primary endpoint, leading the company to halt its development. Instead, Neurocrine will focus on advancing NBI-1117568 for schizophrenia and NBI-1065845 for major depressive disorder. Despite the setback, analysts maintain an Outperform rating on the stock, citing potential in other areas.

Portfolio Pulse from Vandana Singh

September 13, 2024 | 4:00 pm

RPTX

Repare Therapeutics shares rise as the company announces it will present its Phase 1/2 cancer trial data at the ESMO Congress.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 3:44 pm

FLOKIUSD

Floki (FLOKI) is trading flat but is expected to rally in Q4 due to increased usage of its trading bot and presence in sports events. Despite underperforming Dogecoin and Shiba Inu, Floki's trading bot has seen significant volume and user growth.

Portfolio Pulse from Khyathi Dalal

September 13, 2024 | 3:34 pm

BMR

NVDA

BEAMR announced a demonstration of 4K p60 live streaming technology that reduces resource load by 30%-50% without sacrificing quality. This demo will be showcased at IBC 2024 in collaboration with NVIDIA Holoscan for Media.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2024 | 3:33 pm

AAPL

ADBE

GLD

GOOG

META

MSFT

QQQ

RH

SPY

TSLA

Gold has reached a new all-time high, driven by rumors of a 50 basis point interest rate cut. The SPDR Gold Trust (GLD) has shown a breakout on higher volume, indicating strong investor conviction. The Arora Report suggests that if the Fed does not cut rates, a pullback in gold could occur, presenting a buying opportunity. Meanwhile, Adobe's earnings fell short of expectations, while RH showed resilience in high-end consumer spending. Money flows are positive in Apple and Alphabet, neutral in Amazon and NVIDIA, and negative in Microsoft, Meta, and Tesla. SPDR S&P 500 ETF Trust (SPY) sees positive flows, while Invesco QQQ Trust (QQQ) sees negative flows.

Portfolio Pulse from The Arora Report

September 13, 2024 | 3:29 pm